RCM - R1 RCM Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
8.86
-0.56 (-5.94%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close9.42
Open9.12
Bid8.13 x 1300
Ask9.10 x 1300
Day's Range8.71 - 9.38
52 Week Range7.12 - 13.99
Volume1,433,519
Avg. Volume1,169,390
Market Cap1.014B
Beta (5Y Monthly)0.06
PE Ratio (TTM)N/A
EPS (TTM)-0.08
Earnings DateFeb 19, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.90
  • Albert Zimmerli Is The Director of R1 RCM Inc. (NASDAQ:RCM) And They Just Spent US$99k On Shares
    Simply Wall St.

    Albert Zimmerli Is The Director of R1 RCM Inc. (NASDAQ:RCM) And They Just Spent US$99k On Shares

    Whilst it may not be a huge deal, we thought it was good to see that the R1 RCM Inc. (NASDAQ:RCM) Director, Albert...

  • Thomson Reuters StreetEvents

    Edited Transcript of RCM earnings conference call or presentation 20-Feb-20 1:00pm GMT

    Q4 2019 R1 RCM Inc Earnings Call

  • R1 RCM Reports Fourth Quarter and Full Year 2019 Results
    GlobeNewswire

    R1 RCM Reports Fourth Quarter and Full Year 2019 Results

    CHICAGO, Feb. 20, 2020 -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results.

  • ACCESSWIRE

    R1 RCM, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 20, 2020 / R1 RCM, Inc. (NASDAQ:RCM) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 20, 2020 at 8:00 AM ...

  • R1 RCM to Present at the Cowen and Company 40th Annual Health Care Conference
    GlobeNewswire

    R1 RCM to Present at the Cowen and Company 40th Annual Health Care Conference

    CHICAGO, Feb. 18, 2020 -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced.

  • 3 Hidden Gems Setting Up for Big Upside
    TipRanks

    3 Hidden Gems Setting Up for Big Upside

    It’s tempting – really, it is – to just put your investment money into the big-name stocks. After all, they generate the headlines, and they generate some spectacular results. Apple, Microsoft, Amazon, and Google parent Alphabet have all broken above $1 trillion market cap. But the big names aren’t the only ones showing great returns.It’s possible to find smaller stocks with big upsides. Small- and mid-cap companies don’t get the headlines and coverage of the trillion-dollar giants, but smart investors can find powerful returns in this category. We’ve used the TipRanks' Stock Screener tool to sort through the database and find some of these high-potential stocks.Setting the search filters to show us ‘Strong Buy’ small- and mid-cap stocks with greater than 10% upside potential reduced the original field from 6,500 stocks to a more manageable 350. We’ve pulled up three that are reporting earnings this month. They come from different economic sectors, and all three bring real incentives for investors. Let's take a closer look:Silicon Motion Technology (SIMO)We’ll start with a semiconductor chip manufacturer. Silicon Motion designs, develops and markets multimedia chips for consumer electronics. The company’s focus is on NAND flash controllers for solid-state storage devices, along with memory chips for SSDs and USB drives. The niche is a strong one; SIMO has just reported a strong Q4.The company released the Q4 2019 results this past Thursday, February 6. Earnings per share, at 96 cents, were up 17% year-over-year, 39% sequentially, and beat the forecast by 13%. Revenues showed even more impressive gains. At $153.2 million, sales beat the estimates by 7% and were up 39% year-over-year and 24% from Q3. Drilling down, SIMO’s SSD segment was a major gainer, with a 60% sequential revenue gain on a 25% increase in sales.Even better, for investors, the company showed a major increase in cash flow. The quarterly release showed that company operations generated $29.4 million in cash, compared to just $4.1 million in Q3. The improved cash position is good news for the stock dividend, which was increased to $1.40 annually. At this level, the dividend gives a yield of 2.95%, 1.5x higher than the average dividend among S&P listed companies. At a 20% share appreciation in the past 12 months, SIMO has slightly underperformed – but the strong dividend helps make up for that.Looking at the stock for Nomura, analyst Donnie Teng writes, “We believe SIMO’s UFS controllers for Micron are growing fast in terms of sales, which may be able to offset the loss from eMMC controllers for Hynix… We expect SIMO’s enterprise SSD sales to double in 2020F, with a recovery of demand from hyperscale customers… we raise our raise 2021F sales by 7% due to our stronger sales outlook…”Teng’s Buy rating on the stock is supported by a 50% increase in his price target, to $60. This new target suggests room for a 30% upside. (To watch Teng’s track record, click here)How does Teng’s bullish bet weigh in against the Street? It appears the analyst is not the only one enthusiastic on the Taiwan-based SSD firm, with TipRanks analytics demonstrating SIMO as a Strong Buy. Out of 8 analysts tracked in the last 3 months, 6 are bullish on the stock while 2 remain sidelined. With a return potential of nearly 22%, the stock’s consensus target price stands at $56.25. (See Silicon Motion stock analysis at TipRanks)R1 RCM (RCM)Moving on, we come to a revenue cycle management company. R1 RCM is an administrative process used in the American health care industry to track patient revenue from initial appointment through the final balance payment. R1 makes the software that provides these services to US-based health care organizations.The company will provide Q4 results on February 20. Expectations are for an EPS of 4 cents – but R1 has missed the forecasts in both of its last two quarters. Those missed expectation, however, belie otherwise strong results. In Q3, revenues were up 20% year-over-year, to $301.2 million, driven by new customer gains in previous 12 months.R1’s overall position is strong enough that, last month, the company was able to announce the acquisition of SCI Solutions, a competitor based in Seattle, Washington. The move, which cost R1 $190 million, promises future results as SCI bring with it a customer base worth up to $225 million in annual revenue.5-star analyst Steven Halper, of Cantor Fitzgerald, sees reason for optimism in R1, specifically citing the SCI acquisition. He writes, “We view the SCI Solutions acquisition as a solid strategic fit. The company should strengthen R1's capabilities within the front-end of the provider revenue cycle. R1 is building one of strongest end-to-end revenue cycle management platforms in the industry, and the shares offer solid upside from current levels.”Halper’s $17 price target, raised by $2, indicates confidence in a 31% upside and supports his Buy rating. (To watch Halper’s track record, click here)Overall, R1 keeps a Strong Buy consensus rating, based on a unanimous 3 Buys. Shares are a bargain, at just $12.95, especially considering that the average price target of $16.33 suggests an impressive 26% upside potential. (See R1 stock analysis at TipRanks)Nomad Foods, Ltd. (NOMD)With our final stock today, we move to the food industry. Nomad Foods is a frozen food distributor, based in the UK and serving customers around the world. The company has a market cap near $4 billion, and sees $2.2 billion in annual revenue.At the end of this month, NOMD will report Q4 2019 earnings. The forecast is for an EPS of 34 cents, a 1 cent year-over-year gain, but a potential 6 cent sequential gain. The company has beaten earnings forecasts consistently through 2019. Revenue in Q3 was $600.7 million.In recent years, Nomad has faced serious headwinds from the ongoing Brexit maneuverings. Investors were worried about increased tariffs and trade barriers in the event of tit-for-tat political fighting between the UK and the EU. The inability of Theresa May’s government did not inspire confidence. The stock’s potential has recovered somewhat since Boris Johnson’s Parliamentary victory, as the vote’s results unified the British government’s outward stance on Brexit.Reviewing NOMD shares for DA Davidson, analyst Brian Holland cites this point as support for a Buy rating. He writes, “[We] believe that the stock has become more investable, with a layer of uncertainty removed by the vote increasing the likelihood of an orderly Brexit. Nomad has continued to generate organic sales and margin growth year-to-date in spite of the very challenging environment.”Holland’s maintains his $25 price target on the stock, implying an upside here of 25%. (To watch Holland’s track record, click here)All in all, Wall Street loves Nomad Foods' stock, rating it "strong buy" on average. It also doesn’t hurt that its $25.67 average price target implies 30% upside potential from current levels. (See Nomad Foods stock analysis at TipRanks)

  • R1 RCM to Release Fourth Quarter 2019 Results on February 20
    GlobeNewswire

    R1 RCM to Release Fourth Quarter 2019 Results on February 20

    CHICAGO, Feb. 05, 2020 -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced.

  • R1 Expands Physician Practice Footprint with District Medical Group
    GlobeNewswire

    R1 Expands Physician Practice Footprint with District Medical Group

    CHICAGO, Jan. 27, 2020 -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, announced its.

  • R1 RCM Expands Market Reach with Launch of Revenue Cycle Management Solution for Large Physician Groups
    GlobeNewswire

    R1 RCM Expands Market Reach with Launch of Revenue Cycle Management Solution for Large Physician Groups

    CHICAGO, Jan. 22, 2020 -- R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, announced the launch of its.

  • R1 Announces Agreement to Acquire SCI Solutions, a Leading Provider of Digital Patient Engagement Solutions
    GlobeNewswire

    R1 Announces Agreement to Acquire SCI Solutions, a Leading Provider of Digital Patient Engagement Solutions

    R1 RCM Inc. (RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced a definitive agreement to acquire SCI Solutions, Inc. (SCI), a leading provider of SaaS-based scheduling and patient access solutions, for approximately $190 million in cash.

  • Announcing: R1 RCM (NASDAQ:RCM) Stock Soared An Exciting 469% In The Last Three Years
    Simply Wall St.

    Announcing: R1 RCM (NASDAQ:RCM) Stock Soared An Exciting 469% In The Last Three Years

    Investing can be hard but the potential fo an individual stock to pay off big time inspires us. But when you hold the...

  • Rush University System for Health Selects R1 RCM for End-to-End Revenue Cycle Management to Drive Performance Excellence and Accelerate Innovation
    GlobeNewswire

    Rush University System for Health Selects R1 RCM for End-to-End Revenue Cycle Management to Drive Performance Excellence and Accelerate Innovation

    R1 RCM Inc. (RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, announced today that Rush University System for Health (RUSH) has entered into a strategic partnership to achieve revenue cycle performance excellence and accelerate innovation in healthcare. RUSH, an academic health system, is a nationally recognized leader in the delivery of high-quality care and the use of information technology to achieve better outcomes, lower costs and improve the patient experience.

  • R1 RCM to Present at the 38th Annual J.P. Morgan Healthcare Conference
    GlobeNewswire

    R1 RCM to Present at the 38th Annual J.P. Morgan Healthcare Conference

    CHICAGO, Dec. 19, 2019 -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of revenue cycle management services to healthcare providers, today announced its management team will.

  • New Strong Sell Stocks for November 26th
    Zacks

    New Strong Sell Stocks for November 26th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

  • Thomson Reuters StreetEvents

    Edited Transcript of RCM earnings conference call or presentation 5-Nov-19 1:00pm GMT

    Q3 2019 R1 RCM Inc Earnings Call

  • Moody's

    Quorum Health Corporation -- Moody's downgrades Quorum Health's CFR by two notches to Caa2; outlook negative

    Moody's Investors Service ("Moody's") today downgraded the ratings on Quorum Health Corporation ("Quorum"), including the Corporate Family Rating (CFR) to Caa2 from B3 and Probability of Default Rating to Caa2-PD from B3-PD. Moody's also downgraded the ratings on Quorum's senior secured revolving credit facility and term loan to Caa1 from B1, and the rating on its unsecured notes to Caa3 from Caa2.

  • R1 RCM Reports Third Quarter 2019 Results
    GlobeNewswire

    R1 RCM Reports Third Quarter 2019 Results

    CHICAGO, Nov. 05, 2019 -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results.

  • R1 RCM Appoints Vijay Kotte as Executive Vice President, Physician Services
    GlobeNewswire

    R1 RCM Appoints Vijay Kotte as Executive Vice President, Physician Services

    CHICAGO, Oct. 29, 2019 -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced.

  • R1 RCM to Release Third Quarter 2019 Results on November 5
    GlobeNewswire

    R1 RCM to Release Third Quarter 2019 Results on November 5

    CHICAGO, Oct. 17, 2019 -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced.

  • How Many R1 RCM Inc. (NASDAQ:RCM) Shares Have Insiders Sold, In The Last Year?
    Simply Wall St.

    How Many R1 RCM Inc. (NASDAQ:RCM) Shares Have Insiders Sold, In The Last Year?

    It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...

  • R1 RCM to Present at the Cantor Fitzgerald 2019 Global Healthcare Conference
    GlobeNewswire

    R1 RCM to Present at the Cantor Fitzgerald 2019 Global Healthcare Conference

    CHICAGO, Sept. 30, 2019 -- R1 RCM Inc. (NASDAQ: RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced the.

  • Hedge Fund P.A.W. Capital Partners’ Top Stock Picks
    Insider Monkey

    Hedge Fund P.A.W. Capital Partners’ Top Stock Picks

    Peter A. Wright launched P.A.W. Capital Partners back in 1990. He is the fund’s Chief Investment Officer, General Partner and Senior Portfolio Manager ever since. He holds a BS in Chemical Engineering and an MBA from Cornell University. Mr. Wright started off his career at I.B.M, later moving to Gartner Group where he worked as an […]

  • R1 RCM Appoints Richard Evans as Interim CFO
    GlobeNewswire

    R1 RCM Appoints Richard Evans as Interim CFO

    Follows Resignation of Christopher Ricaurte Raises 2019 Adjusted EBITDA Outlook CHICAGO, Sept. 24, 2019 -- R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue.

  • Thomson Reuters StreetEvents

    Edited Transcript of RCM earnings conference call or presentation 6-Aug-19 12:00pm GMT

    Q2 2019 R1 RCM Inc Earnings Call

  • These 4 Measures Indicate That R1 RCM (NASDAQ:RCM) Is Using Debt Reasonably Well
    Simply Wall St.

    These 4 Measures Indicate That R1 RCM (NASDAQ:RCM) Is Using Debt Reasonably Well

    David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...